TMS for OCD: Deep Brain Stimulation Without Surgery

Obsessive-compulsive disorder is one of the most stubborn psychiatric conditions to treat. Standard first-line approaches (SSRIs and exposure-response prevention therapy) help many people, but a significant portion of OCD patients remain symptomatic even after aggressive treatment. For these patients, deep transcranial magnetic stimulation (deep TMS) represents something genuinely new: a way to modulate the overactive brain circuits driving OCD, without surgery, without sedation, and without adding another medication to the mix.

The FDA cleared deep TMS for OCD in 2018, making it the first non-invasive device specifically approved for this condition. The approach is different from TMS for depression in critical ways: different brain target, different coil, and an unusual treatment method that involves deliberately triggering OCD symptoms during sessions. Here is what the evidence says and what you should know if you are considering this option.

How OCD Works in the Brain

To understand why TMS targets specific brain areas for OCD, it helps to understand what goes wrong neurologically.

OCD involves a brain circuit called the cortico-striato-thalamo-cortical (CSTC) loop. In healthy brains, this circuit helps you detect potential threats, generate appropriate concern, and then move on once the threat is evaluated. In OCD, this circuit gets stuck in a hyperactive loop. The brain keeps signaling “something is wrong” even after you have checked, washed, or reassured yourself dozens of times (1).

Key regions involved include:

• Medial prefrontal cortex (mPFC): Involved in self-referential processing and error monitoring. Overactivity here contributes to the persistent feeling that something is “not right”
• Anterior cingulate cortex (ACC): Acts as the brain’s conflict detector. In OCD, the ACC is hyperactive, constantly flagging perceived errors and conflicts that don’t actually exist
• Orbitofrontal cortex (OFC): Processes reward and threat signals. Overactivity drives the overwhelming urge to perform compulsions
• Striatum (caudate nucleus): Acts as a relay station in the CSTC loop. Abnormal activity here perpetuates the cycle of obsessions and compulsions

Neuroimaging studies consistently show that these regions are more active in people with OCD, both at rest and when symptoms are provoked. Successful treatment (whether by medication, therapy, or brain stimulation) tends to normalize activity in this circuit (2).

How Deep TMS for OCD Differs from TMS for Depression

If you have heard of TMS for depression, it is essential to understand that TMS for OCD is a fundamentally different treatment. The similarities are limited to the basic technology (magnetic pulses delivered through a coil). Almost everything else differs.

The H7 coil is specifically designed to reach the mPFC and ACC, which sit along the brain’s midline and are deeper than the lateral DLPFC targeted in depression. The standard figure-8 coil used for depression simply cannot reach these structures effectively (3).

The Symptom Provocation Approach

This is the most distinctive element of deep TMS for OCD, and the part that patients find most counterintuitive.

Before each TMS session, you spend about 5 minutes doing something that deliberately triggers your OCD symptoms. The specifics depend on your particular OCD subtype:

• Contamination OCD: touching a “contaminated” object without washing
• Checking OCD: being shown an image of an unlocked door or unsecured appliance
• Symmetry/ordering OCD: viewing a deliberately disordered arrangement
• Harm OCD: reading a scenario related to harm themes

The logic behind this approach is grounded in neuroscience. When OCD symptoms are triggered, the CSTC circuit activates. Delivering magnetic stimulation to these circuits while they are active may be more effective at modulating them than stimulating them in their resting state. Think of it like this: you have to turn on the malfunctioning circuit to reset it (4).

This is conceptually similar to the principle behind exposure-response prevention (ERP) therapy, where you deliberately confront triggers to weaken the OCD cycle. Deep TMS adds a neurobiological intervention on top of that exposure.

What the Evidence Shows

The pivotal study that led to FDA clearance was a multicenter, randomized, sham-controlled trial published in the American Journal of Psychiatry in 2019. Key findings:

• 99 OCD patients who had not responded adequately to medication were randomized to active deep TMS or sham treatment
• After 6 weeks of daily treatment, 38.1% of the active group showed a clinically meaningful response (defined as a 30% or greater reduction in Y-BOCS score), compared to 11.1% in the sham group
• The response rate continued to improve after treatment ended, with 45.2% of the active group meeting response criteria at 10-week follow-up
• The treatment was well-tolerated, with headache being the most common side effect (5)

A 38% response rate might sound modest, but context matters enormously. These were patients who had already failed first-line treatments. In this population, any intervention that helps more than a third of patients is clinically meaningful.

Real-world data has been encouraging. A 2021 naturalistic study of 219 OCD patients treated with deep TMS in clinical practice found a response rate of approximately 57%, higher than the pivotal trial. This pattern (better real-world results than clinical trial results) mirrors what has been seen with TMS for depression and likely reflects greater clinical flexibility in treatment duration and parameters (6).

The Treatment Protocol

A standard deep TMS for OCD protocol looks like this:

Initial assessment. A psychiatrist evaluates your OCD severity (typically using the Yale-Brown Obsessive Compulsive Scale, or Y-BOCS), reviews your treatment history, identifies your specific OCD triggers for the provocation component, and ensures you are medically appropriate for TMS.

Treatment phase. Daily sessions (5 days per week) for 6 weeks, totaling approximately 29 to 30 sessions. Each session follows this pattern:

1. Symptom provocation (approximately 5 minutes): Individualized exposure to your OCD triggers
2. Deep TMS stimulation (approximately 20 minutes): The H7 coil delivers 20 Hz pulses to the mPFC/ACC region
3. Brief check-in: How was the session? Any concerns?

Post-treatment monitoring. Regular follow-up appointments to assess response and determine whether maintenance sessions are warranted.

Most patients can drive themselves to and from appointments and return to normal activities immediately after each session. The total time commitment per session is about 30 to 40 minutes including the provocation component.

Deep TMS vs. ERP Therapy vs. Medication for OCD

These treatments are not mutually exclusive. Many patients do best with a combination approach. Deep TMS may help reduce OCD symptom severity enough that ERP therapy becomes more tolerable and effective. Continuing an SSRI during and after TMS treatment is common and often recommended (7).

Who Is a Good Candidate

Deep TMS for OCD is most appropriate for patients who:

• Have a confirmed diagnosis of OCD (not just “OCD tendencies” or anxiety with some obsessive features)
• Have tried at least one adequate trial of an SSRI at OCD-appropriate doses (which are typically higher than doses used for depression)
• Have tried ERP therapy and either not responded sufficiently or could not tolerate the exposure component
• Have moderate to severe OCD that significantly impacts daily functioning
• Can commit to the 6-week daily treatment schedule

Cost and Insurance Coverage

Insurance coverage for deep TMS for OCD is improving but remains less consistent than coverage for TMS for depression. Factors that influence coverage:

• Some major insurers now cover deep TMS for OCD, particularly after documented failure of both medication and ERP therapy
• Prior authorization is almost always required
• Coverage tends to be better with PPO plans than HMO plans
• Some plans classify it as experimental, which can complicate appeals

Out-of-pocket cost for a full 6-week course typically ranges from $8,000 to $15,000 without insurance. With insurance coverage, copays and coinsurance can bring out-of-pocket costs to $1,500 to $4,000.

Given that severe OCD can be profoundly disabling (lost work, destroyed relationships, inability to function independently), many patients and families consider this a worthwhile investment when other treatments have failed.

What to Expect Long-Term

The durability of deep TMS for OCD is still being studied. Data from the pivotal trial showed that many responders maintained their gains at 10-week follow-up, and longer-term naturalistic data suggests that benefits can persist for months.

Some patients do experience symptom return over time. Options for maintaining improvement include:

• Maintenance TMS sessions: Periodic booster sessions (weekly, then tapering) after the initial course
• Combining with ERP: Starting or resuming ERP therapy after TMS has reduced symptom severity
• Continuing medication: Maintaining SSRI treatment alongside and after TMS
• Repeat courses: Some patients undergo another full course of TMS if symptoms return significantly

The emerging picture suggests that deep TMS works best as one component of a broader OCD management strategy rather than a standalone cure.

Surgical Alternatives: When TMS Is Not Enough

For patients with severe, truly refractory OCD (those who have not responded to multiple medications, ERP, and TMS), surgical options exist. These include deep brain stimulation (DBS), which involves implanting electrodes in specific brain regions, and ablative neurosurgery procedures like anterior cingulotomy or capsulotomy.

Deep TMS is sometimes described as “deep brain stimulation without surgery,” and while the comparison captures something true (both target deep brain structures involved in OCD), it overstates the similarity. DBS involves permanent electrode implantation and continuous stimulation, making it far more invasive but also potentially more powerful for the most severe cases. Deep TMS is non-invasive and time-limited, making it appropriate much earlier in the treatment sequence (8).

Finding a Provider

Deep TMS for OCD requires the BrainsWay H7 coil, which is not the same equipment used for depression. Not every TMS clinic offers it. When searching for a provider:

• Confirm they have the BrainsWay system with the H7 coil specifically cleared for OCD
• Ask about their experience treating OCD patients (not just depression)
• Ensure a psychiatrist with OCD expertise is involved in treatment planning
• Ask how they handle symptom provocation and whether it is individualized to your specific OCD presentation
• Inquire about their maintenance protocol and follow-up plan

The Bottom Line

Deep TMS for OCD is a genuine therapeutic advance for a condition that desperately needs more treatment options. It does not work for everyone, and it is not a replacement for the proven combination of medication and ERP therapy. But for the substantial number of OCD patients who remain severely symptomatic despite first-line treatments, deep TMS offers a safe, non-invasive way to directly modulate the brain circuits that drive the disorder.

The 2018 FDA clearance marked a meaningful milestone. As more clinics adopt the technology, more patients are treated, and longer-term data accumulates, the role of deep TMS in OCD treatment will become clearer. For now, it fills an important gap between conventional treatments and surgical options, giving treatment-resistant patients a viable next step.

References

1. Saxena S, Rauch SL. (2000). Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatric Clinics of North America, 23(3), 563-586. doi:10.1016/S0193-953X(05)70181-7
2. Menzies L, et al. (2008). Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neuroscience and Biobehavioral Reviews, 32(3), 525-549. doi:10.1016/j.neubiorev.2007.09.005
3. Roth Y, Amir A, Levkovitz Y, Zangen A. (2007). Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils. Journal of Clinical Neurophysiology, 24(1), 31-38. doi:10.1097/WNP.0b013e31802fa393
4. Carmi L, et al. (2018). Clinical and electrophysiological outcomes of deep TMS over the medial prefrontal and anterior cingulate cortices in OCD patients. Brain Stimulation, 11(1), 158-165. doi:10.1016/j.brs.2017.09.004
5. Carmi L, et al. (2019). Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a prospective multicenter randomized double-blind placebo-controlled trial. American Journal of Psychiatry, 176(11), 931-938. doi:10.1176/appi.ajp.2019.18101180
6. Roth Y, et al. (2021). Real-world efficacy of deep TMS for obsessive-compulsive disorder: post-marketing data collected from 22 clinical sites. Journal of Psychiatric Research, 137, 667-672. doi:10.1016/j.jpsychires.2020.11.009
7. Swierkosz-Lenart K, et al. (2023). Combining deep TMS and ERP for treatment-resistant OCD: a case series. Frontiers in Psychiatry, 14, 1108539. doi:10.3389/fpsyt.2023.1108539
8. Greenberg BD, et al. (2010). Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Molecular Psychiatry, 15(1), 64-79. doi:10.1038/mp.2008.55

Related Reading

• Complete Guide to TMS Therapy
• TMS for Depression: How It Treats Treatment-Resistant Depression
• TMS for Anxiety: Evidence, Protocols, and What to Expect
• Neurofeedback for ADHD: Training Your Brain Without Medication